Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05008276 · ClinicalTrials.gov registry record
Puberty, Diabetes, and the Kidneys, When Eustress Becomes Distress (PANTHER Study)
A clinical trial of Type 2 Diabetes Mellitus and Pre Diabetes, sponsored by Petter Bjornstad.
- Recruiting
- Registry status
- 100
- Enrollment target
- 2
- Study locations
NCT05008276 is a study of Type 2 Diabetes Mellitus and Pre Diabetes that is actively recruiting participants, run by Petter Bjornstad. The registered enrollment target is 100 participants, below the 2,748-participant average among 122 other Type 2 Diabetes Mellitus trials with a reported enrollment target (96% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT05008276, a study of Type 2 Diabetes Mellitus and Pre Diabetes, is actively recruiting participants, sponsored by Petter Bjornstad.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 2
- Study locations
Study Summary
Early diabetic kidney disease (DKD) occurs in 50-70% of youth with type 2 diabetes (T2D) and confers high lifetime risk of dialysis and premature death. Youth-onset T2D typically manifests during or shortly after puberty in adolescents with obesity. Epidemiological data implicate puberty as an accelerator of kidney disease in youth with obesity and diabetes and the investigators posit that the link between puberty and T2D-onset may explain the high burden of DKD in youth-onset T2D. A better understanding of the impact of puberty on kidney health is needed to promote preservation of native kidney function, especially in youth with T2D.
Conditions Studied
Interventions
- DRUG Aminohippurate Sodium Inj 20%
- DRUG Iohexol Inj 300 MG/ML
- DRUG Dextran 40
Study Locations (2)
Colorado
- Children's Hospital Colorado - Aurora
Washington
- Seattle Children's Hospital - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2021-09-27 |
| Est. Completion | 2027-12-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05008276
The ClinicalTrials.gov registry entry for NCT05008276 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,748-participant average among 122 other Type 2 Diabetes Mellitus trials with a reported enrollment target (96% lower). The listed sponsor is Petter Bjornstad, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 6 conditions, with Type 2 Diabetes Mellitus appearing as the primary indexed condition, and to 3 interventions - of which Aminohippurate Sodium Inj 20% is the first listed.
NCT05008276 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Colorado, Washington.
Frequently Asked Questions
What is clinical trial NCT05008276 about?
NCT05008276 is a clinical study titled "Puberty, Diabetes, and the Kidneys, When Eustress Becomes Distress (PANTHER Study)". Early diabetic kidney disease (DKD) occurs in 50-70% of youth with type 2 diabetes (T2D) and confers high lifetime risk of dialysis and premature death. Youth-onset T2D typically manifests during or shortly after puberty in adolescents with obesity. Epidemiological data implicate puberty as an accel...
What is the current status of trial NCT05008276?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2021-09-27. Estimated completion is 2027-12-01.
What conditions does trial NCT05008276 study?
This clinical trial studies the following conditions: Type 2 Diabetes Mellitus, Pre Diabetes, Diabetic Kidney Disease, Adolescent Obesity, Puberty.
What interventions are being tested in trial NCT05008276?
The interventions under investigation include: Aminohippurate Sodium Inj 20% (DRUG), Iohexol Inj 300 MG/ML (DRUG), Dextran 40 (DRUG).
Who is sponsoring clinical trial NCT05008276?
This trial is sponsored by Petter Bjornstad, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05008276 being conducted?
This trial has 2 study locations across Colorado, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Type 2 Diabetes Mellitus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The PRECISION II Study: Evaluating the Accuracy of the LabPatch Glucose Sensing System
RECRUITING
-
A Study to Evaluate the Effect of Maridebart Cafraglutide on Insulin Sensitivity and β-cell Function in Participants With Type 2 Diabetes Mellitus
RECRUITING · Phase 1
-
An Observational Study Called FINEROD to Learn More About the Use of the Treatment Finerenone Including How Safe it is and How Well it Works Under Real-world Conditions
RECRUITING
-
Preventing Type 2 Diabetes in Black Emergent Adult
RECRUITING · NA
-
A Study to Evaluate Pharmacokinetics of LY3209590 in Pediatric Participants With Type 2 Diabetes Mellitus
RECRUITING · Phase 1
-
A Study to Compare Different Doses of RO7795081 With a Placebo or Semaglutide in People With Type 2 Diabetes
RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.